CYTK vs NBIX
Cytokinetics vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | CYTK | NBIX |
|---|---|---|
| AI Score | 57 | 63 |
| Price | $80.15 | — |
| P/E Ratio | -11.74× | 25.47× |
| ROE | 1.2% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.9% | 1.0% |
| Debt / Equity | -1.56× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 36.4 | 45.1 |
| Beta | 0.422 | 0.386 |
| Expected Upside | +37.1% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CYTK Full Analysis
NBIX Full Analysis